SYNLAIT MILK LIMITED (SM1)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SM1 - SYNLAIT MILK LIMITED

FNArena Sector : Dairy
Year End: July
GICS Industry Group : Food, Beverage & Tobacco
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.02

21 Sep
2021

-0.030

OPEN

$3.00

-0.98%

HIGH

$3.07

60,165

LOW

$2.98

TARGET
$2.55 -15.6% downside
OTHER COMPANIES IN THE SAME SECTOR
A2M . BGA . MGC . FSF . NUC . BUB . BFC . TFL . NUC .
FNARENA'S MARKET CONSENSUS FORECASTS
SM1: 1
Title FY21
Forecast
FY22
Forecast
EPS (cps) - 10.6 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201520162017201820192020
EPS Basic xxxxxxxxxxxxxxx39.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx1,232.9 M
Book Value Per Share xxxxxxxxxxxxxxx314.2
Net Operating Cash Flow xxxxxxxxxxxxxxx78.2 M
Net Profit Margin xxxxxxxxxxxxxxx5.78 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201520162017201820192020
Return on Assets xxxxxxxxxxxxxxx5.72 %
Return on Equity xxxxxxxxxxxxxxx13.76 %
Return on Total Capital xxxxxxxxxxxxxxx12.55 %
Capex xxxxxxxxxxxxxxx144.4 M
Capex % of Sales xxxxxxxxxxxxxxx11.71 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-53.6 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

25/05/2021

3

Upgrade to Hold from Reduce

$2.55

-15.56%

Despite FY21 guidance being lowered to a loss of -NZ$20-30m from March’s breakeven expectation, Morgans believes issues will be largely confined to FY21. The rating rises to Hold from Reduce and the target price falls to $2.55 from $2.58.

The broker explains lower guidance was due to ongoing shipping delays and lower-than-expected ingredient sales prices due to sales phasing impacts and volume pressure. Also, there's a more conservative approach to year-end inventory volumes and valuations.

The analyst feels investors could start to look through existing issues if the company can start to rebuild confidence in a FY22 earnings recovery at the FY21 result. The broker continues to believe gearing is too high though management states a raising is not in prospect. 

FORECAST
Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of minus -11.24 cents.
Morgans forecasts a full year FY22 dividend of 0.00 cents and EPS of 16.86 cents.

Credit Suisse

xx/xx/xxxx

0

xxxxxxxxx xx xxxxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

SM1 STOCK CHART